Skip to main content
Erschienen in: Cancer and Metastasis Reviews 1-2/2012

01.06.2012 | NON-THEMATIC REVIEW

Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance

verfasst von: David Tarin

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 1-2/2012

Einloggen, um Zugang zu erhalten

Abstract

This article provides a broad overview of the field of inappropriate gene expression in many organisms across the animal and plant kingdoms as well as its importance to human disease in general and cancer in particular. Study of the topic is especially important for understanding how the chaotic maelstrom of evolving and cascading regulatory genetic interactions in an advancing cancer produces its clinical effects and for designing pragmatic solutions to how such disorder might eventually be tamed. It is emphasized that the topic warrants much more attention in research and in clinical practice because of the added value it brings to refining cancer diagnosis and treatment and to the assessment of prognostic markers. It is also particularly relevant to understanding the etiology and extensive clinical manifestations of paraneoplastic syndromes affecting multiple organs remote from the tumor and the treatment or amelioration of the substantial morbidity that they cause in cancer patients. More broadly, inappropriate expression can be caused by a number of mechanisms including mutations, rearrangements of the genome, and viral insertions and, under prolonged selection pressures, also has the potential to be an agent of evolutionary change.
Literatur
1.
Zurück zum Zitat Wood, I. C., Gray, N. K., & Jones, L. (2009). Gene expression in neuronal disease. Biochemical Society Transactions, 37(Pt 6), 1261–1262.PubMedCrossRef Wood, I. C., Gray, N. K., & Jones, L. (2009). Gene expression in neuronal disease. Biochemical Society Transactions, 37(Pt 6), 1261–1262.PubMedCrossRef
2.
Zurück zum Zitat Suzuki, M., & Tarin, D. (2007). Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications. Molecular Oncology, 1(2), 172–180.PubMedCrossRef Suzuki, M., & Tarin, D. (2007). Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications. Molecular Oncology, 1(2), 172–180.PubMedCrossRef
3.
Zurück zum Zitat Montel, V., Suzuki, M., Galloy, C., Mose, E. S., & Tarin, D. (2009). Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation, 78(5), 283–291.PubMedCrossRef Montel, V., Suzuki, M., Galloy, C., Mose, E. S., & Tarin, D. (2009). Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation, 78(5), 283–291.PubMedCrossRef
4.
Zurück zum Zitat Montel, V., Huang, T. Y., Mose, E., Pestonjamasp, K., & Tarin, D. (2005). Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. American Journal of Pathology, 166(5), 1565–1579.PubMedCrossRef Montel, V., Huang, T. Y., Mose, E., Pestonjamasp, K., & Tarin, D. (2005). Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. American Journal of Pathology, 166(5), 1565–1579.PubMedCrossRef
5.
Zurück zum Zitat Agarwal, D., Goodison, S., Nicholson, B., Tarin, D., & Urquidi, V. (2003). Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model. Differentiation, 71(2), 114–125.PubMedCrossRef Agarwal, D., Goodison, S., Nicholson, B., Tarin, D., & Urquidi, V. (2003). Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model. Differentiation, 71(2), 114–125.PubMedCrossRef
6.
Zurück zum Zitat Heppner, G. H. (1984). Tumor heterogeneity. Cancer Research, 44(6), 2259–2265.PubMed Heppner, G. H. (1984). Tumor heterogeneity. Cancer Research, 44(6), 2259–2265.PubMed
7.
Zurück zum Zitat Kruger, S., Thorns, C., Bohle, A., & Feller, A. C. (2003). Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder. International Urology and Nephrology, 35(2), 169–173.PubMedCrossRef Kruger, S., Thorns, C., Bohle, A., & Feller, A. C. (2003). Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder. International Urology and Nephrology, 35(2), 169–173.PubMedCrossRef
8.
Zurück zum Zitat Fidler, I. J. (1978). Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Research, 38(9), 2651–2660.PubMed Fidler, I. J. (1978). Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Research, 38(9), 2651–2660.PubMed
9.
Zurück zum Zitat Tarin, D. (1976). Cellular interactions in neoplasia. In L. Weiss (Ed.), Fundamental aspects of metastasis (pp. 151–187). Amsterdam: North Holland. Tarin, D. (1976). Cellular interactions in neoplasia. In L. Weiss (Ed.), Fundamental aspects of metastasis (pp. 151–187). Amsterdam: North Holland.
10.
Zurück zum Zitat Tarin, D. (1972). Morphological studies on the mechanism of carcinogenesis. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 227–289). London: Academic. Tarin, D. (1972). Morphological studies on the mechanism of carcinogenesis. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 227–289). London: Academic.
11.
Zurück zum Zitat Tarin, D. (1967). Sequential electron microscopical study of experimental mouse skin carcinogenesis. International Journal of Cancer, 2(3), 195–211.CrossRef Tarin, D. (1967). Sequential electron microscopical study of experimental mouse skin carcinogenesis. International Journal of Cancer, 2(3), 195–211.CrossRef
12.
Zurück zum Zitat Tarin, D. (1969). Fine structure of murine mammary tumours: The relationship between epithelium and connective tissue in neoplasms induced by various agents. British Journal of Cancer, 23(2), 417–425.PubMedCrossRef Tarin, D. (1969). Fine structure of murine mammary tumours: The relationship between epithelium and connective tissue in neoplasms induced by various agents. British Journal of Cancer, 23(2), 417–425.PubMedCrossRef
13.
Zurück zum Zitat Tarin, D. (1972). Tissue interactions in carcinogenesis. London: Academic. Tarin, D. (1972). Tissue interactions in carcinogenesis. London: Academic.
14.
Zurück zum Zitat Tarin, D. (1968). Further electron microscopic studies on the mechanism of carcinogenesis: The specificity of the changes in carcinogen-treated mouse skin. International Journal of Cancer, 3(6), 734–742.CrossRef Tarin, D. (1968). Further electron microscopic studies on the mechanism of carcinogenesis: The specificity of the changes in carcinogen-treated mouse skin. International Journal of Cancer, 3(6), 734–742.CrossRef
15.
Zurück zum Zitat Tarin, D., & Croft, C. B. (1970). Ultrastructural studies of wound healing in mouse skin. II. Dermo-epidermal interrelationships. Journal of Anatomy, 106(Pt 1), 79–91.PubMed Tarin, D., & Croft, C. B. (1970). Ultrastructural studies of wound healing in mouse skin. II. Dermo-epidermal interrelationships. Journal of Anatomy, 106(Pt 1), 79–91.PubMed
16.
Zurück zum Zitat Matsumura, Y., & Tarin, D. (1992). Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340(8827), 1053–1058.PubMedCrossRef Matsumura, Y., & Tarin, D. (1992). Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340(8827), 1053–1058.PubMedCrossRef
17.
Zurück zum Zitat Matsumura, Y., Sugiyama, M., Matsumura, S., et al. (1995). Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. The Journal of Pathology, 177(1), 11–20.PubMedCrossRef Matsumura, Y., Sugiyama, M., Matsumura, S., et al. (1995). Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. The Journal of Pathology, 177(1), 11–20.PubMedCrossRef
18.
Zurück zum Zitat Tarin, D., Hoyt, B. J., & Evans, D. J. (1982). Correlation of collagenase secretion with metastatic-colonization potential in naturally occurring murine mammary tumours. British Journal of Cancer, 46(2), 266–278.PubMedCrossRef Tarin, D., Hoyt, B. J., & Evans, D. J. (1982). Correlation of collagenase secretion with metastatic-colonization potential in naturally occurring murine mammary tumours. British Journal of Cancer, 46(2), 266–278.PubMedCrossRef
19.
Zurück zum Zitat Shields, S. E., Ogilvie, D. J., McKinnell, R. G., & Tarin, D. (1984). Degradation of basement membrane collagens by metalloproteases released by human, murine and amphibian tumours. The Journal of Pathology, 143(3), 193–197.PubMedCrossRef Shields, S. E., Ogilvie, D. J., McKinnell, R. G., & Tarin, D. (1984). Degradation of basement membrane collagens by metalloproteases released by human, murine and amphibian tumours. The Journal of Pathology, 143(3), 193–197.PubMedCrossRef
20.
Zurück zum Zitat Ogilvie, D. J., Hailey, J. A., Juacaba, S. F., Lee, E. C., & Tarin, D. (1985). Collagenase secretion by human breast neoplasms: A clinicopathologic investigation. Journal of the National Cancer Institute, 74(1), 19–27.PubMed Ogilvie, D. J., Hailey, J. A., Juacaba, S. F., Lee, E. C., & Tarin, D. (1985). Collagenase secretion by human breast neoplasms: A clinicopathologic investigation. Journal of the National Cancer Institute, 74(1), 19–27.PubMed
21.
Zurück zum Zitat Ogilvie, D. J., McKinnell, R. G., & Tarin, D. (1984). Temperature-dependent elaboration of collagenase by the renal adenocarcinoma of the leopard frog, Rana pipiens. Cancer Research, 44(8), 3438–3441.PubMed Ogilvie, D. J., McKinnell, R. G., & Tarin, D. (1984). Temperature-dependent elaboration of collagenase by the renal adenocarcinoma of the leopard frog, Rana pipiens. Cancer Research, 44(8), 3438–3441.PubMed
22.
Zurück zum Zitat Bao, L., Pigott, R., Matsumura, Y., Baban, D., & Tarin, D. (1993). Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines. Differentiation, 52(3), 239–246.PubMedCrossRef Bao, L., Pigott, R., Matsumura, Y., Baban, D., & Tarin, D. (1993). Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines. Differentiation, 52(3), 239–246.PubMedCrossRef
23.
Zurück zum Zitat Cailleau, R., Olive, M., & Cruciger, Q. V. (1978). Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro, 14(11), 911–915.PubMedCrossRef Cailleau, R., Olive, M., & Cruciger, Q. V. (1978). Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro, 14(11), 911–915.PubMedCrossRef
24.
Zurück zum Zitat Urquidi, V., Sloan, D., Kawai, K., et al. (2002). Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clinical Cancer Research, 8(1), 61–74.PubMed Urquidi, V., Sloan, D., Kawai, K., et al. (2002). Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clinical Cancer Research, 8(1), 61–74.PubMed
25.
Zurück zum Zitat Goodison, S., Kawai, K., Hihara, J., et al. (2003). Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clinical Cancer Research, 9(10 Pt 1), 3808–3814.PubMed Goodison, S., Kawai, K., Hihara, J., et al. (2003). Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clinical Cancer Research, 9(10 Pt 1), 3808–3814.PubMed
26.
Zurück zum Zitat Montel, V., Kleeman, J., Agarwal, D., Spinella, D., Kawai, K., & Tarin, D. (2004). Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Research, 64(5), 1687–1694.PubMedCrossRef Montel, V., Kleeman, J., Agarwal, D., Spinella, D., Kawai, K., & Tarin, D. (2004). Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Research, 64(5), 1687–1694.PubMedCrossRef
27.
Zurück zum Zitat Montel, V., Mose, E. S., & Tarin, D. (2006). Tumor–stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. International Journal of Cancer, 119(2), 251–263.CrossRef Montel, V., Mose, E. S., & Tarin, D. (2006). Tumor–stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. International Journal of Cancer, 119(2), 251–263.CrossRef
28.
Zurück zum Zitat Suzuki, M., Mose, E., Galloy, C., & Tarin, D. (2007). Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts. American Journal of Pathology, 171(2), 682–692.PubMedCrossRef Suzuki, M., Mose, E., Galloy, C., & Tarin, D. (2007). Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts. American Journal of Pathology, 171(2), 682–692.PubMedCrossRef
29.
Zurück zum Zitat Suzuki, M., Mose, E. S., Montel, V., & Tarin, D. (2006). Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. American Journal of Pathology, 169(2), 673–681.PubMedCrossRef Suzuki, M., Mose, E. S., Montel, V., & Tarin, D. (2006). Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. American Journal of Pathology, 169(2), 673–681.PubMedCrossRef
30.
Zurück zum Zitat Ross, D. T., Scherf, U., Eisen, M. B., et al. (2000). Systematic variation in gene expression patterns in human cancer cell lines. Nature Genetics, 24(3), 227–235.PubMedCrossRef Ross, D. T., Scherf, U., Eisen, M. B., et al. (2000). Systematic variation in gene expression patterns in human cancer cell lines. Nature Genetics, 24(3), 227–235.PubMedCrossRef
31.
Zurück zum Zitat Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007). MDA-MB-435 cells are derived from M14 melanoma cells—A loss for breast cancer, but a boon for melanoma research. Breast Cancer Research and Treatment, 104(1), 13–19.PubMedCrossRef Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007). MDA-MB-435 cells are derived from M14 melanoma cells—A loss for breast cancer, but a boon for melanoma research. Breast Cancer Research and Treatment, 104(1), 13–19.PubMedCrossRef
32.
Zurück zum Zitat Jessani, N., Liu, Y., Humphrey, M., & Cravatt, B. F. (2002). Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proceedings of the National Academy of Sciences of the United States of America, 99(16), 10335–10340.PubMedCrossRef Jessani, N., Liu, Y., Humphrey, M., & Cravatt, B. F. (2002). Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proceedings of the National Academy of Sciences of the United States of America, 99(16), 10335–10340.PubMedCrossRef
33.
Zurück zum Zitat Ellison, G., Klinowska, T., Westwood, R. F., Docter, E., French, T., & Fox, J. C. (2002). Further evidence to support the melanocytic origin of MDA-MB-435. Molecular Pathology, 55(5), 294–299.PubMedCrossRef Ellison, G., Klinowska, T., Westwood, R. F., Docter, E., French, T., & Fox, J. C. (2002). Further evidence to support the melanocytic origin of MDA-MB-435. Molecular Pathology, 55(5), 294–299.PubMedCrossRef
34.
Zurück zum Zitat Chambers, A. F. (2009). MDA-MB-435 and M14 cell lines: Identical but not M14 melanoma? Cancer Research, 69(13), 5292–5293.PubMedCrossRef Chambers, A. F. (2009). MDA-MB-435 and M14 cell lines: Identical but not M14 melanoma? Cancer Research, 69(13), 5292–5293.PubMedCrossRef
35.
Zurück zum Zitat Sellappan, S., Grijalva, R., Zhou, X., et al. (2004). Lineage infidelity of MDA-MB-435 cells: Expression of melanocyte proteins in a breast cancer cell line. Cancer Research, 64(10), 3479–3485.PubMedCrossRef Sellappan, S., Grijalva, R., Zhou, X., et al. (2004). Lineage infidelity of MDA-MB-435 cells: Expression of melanocyte proteins in a breast cancer cell line. Cancer Research, 64(10), 3479–3485.PubMedCrossRef
36.
Zurück zum Zitat Braun, A. C. (1981). An epigenetic model for the origin of cancer. The Quarterly Review of Biology, 56(1), 33–60.PubMedCrossRef Braun, A. C. (1981). An epigenetic model for the origin of cancer. The Quarterly Review of Biology, 56(1), 33–60.PubMedCrossRef
37.
Zurück zum Zitat Warr, G. (1981). The evolution of the lymphocyte. Immunology Today, 2, 63–68.CrossRef Warr, G. (1981). The evolution of the lymphocyte. Immunology Today, 2, 63–68.CrossRef
38.
Zurück zum Zitat Cooper, M., & Alder, N. (2006). The evolution of adaptive immunity systems. Cell, 124, 815–822.PubMedCrossRef Cooper, M., & Alder, N. (2006). The evolution of adaptive immunity systems. Cell, 124, 815–822.PubMedCrossRef
39.
Zurück zum Zitat Attwood, H. D., & Park, W. W. (1961). Embolism to the lungs by trophoblast. The Journal of Obstetrics and Gynaecology of the British Commonwealth, 68, 611–617.PubMedCrossRef Attwood, H. D., & Park, W. W. (1961). Embolism to the lungs by trophoblast. The Journal of Obstetrics and Gynaecology of the British Commonwealth, 68, 611–617.PubMedCrossRef
40.
Zurück zum Zitat Carstens, P. H. (1969). Pulmonary bone marrow embolism following external cardiac massage. Acta Pathologica et Microbiologica Scandinavica, 76(4), 510–514.PubMedCrossRef Carstens, P. H. (1969). Pulmonary bone marrow embolism following external cardiac massage. Acta Pathologica et Microbiologica Scandinavica, 76(4), 510–514.PubMedCrossRef
41.
Zurück zum Zitat Muller, A., Homey, B., Soto, H., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410(6824), 50–56.PubMedCrossRef Muller, A., Homey, B., Soto, H., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410(6824), 50–56.PubMedCrossRef
42.
Zurück zum Zitat Zeelenberg, I. S., Ruuls-Van Stalle, L., & Roos, E. (2003). The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Research, 63(13), 3833–3839.PubMed Zeelenberg, I. S., Ruuls-Van Stalle, L., & Roos, E. (2003). The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Research, 63(13), 3833–3839.PubMed
43.
Zurück zum Zitat Gunthert, U., Hofmann, M., Rudy, W., et al. (1991). A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65(1), 13–24.PubMedCrossRef Gunthert, U., Hofmann, M., Rudy, W., et al. (1991). A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65(1), 13–24.PubMedCrossRef
44.
Zurück zum Zitat Barbour, A. P., Reeder, J. A., Walsh, M. D., Fawcett, J., Antalis, T. M., & Gotley, D. C. (2003). Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3. Cancer Research, 63(4), 887–892.PubMed Barbour, A. P., Reeder, J. A., Walsh, M. D., Fawcett, J., Antalis, T. M., & Gotley, D. C. (2003). Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3. Cancer Research, 63(4), 887–892.PubMed
45.
Zurück zum Zitat Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001). Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proceedings of the National Academy of Sciences of the United States of America, 98(6), 3352–3357.PubMedCrossRef Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001). Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proceedings of the National Academy of Sciences of the United States of America, 98(6), 3352–3357.PubMedCrossRef
46.
Zurück zum Zitat Borsig, L., Wong, R., Hynes, R. O., Varki, N. M., & Varki, A. (2002). Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proceedings of the National Academy of Sciences of the United States of America, 99(4), 2193–2198.PubMedCrossRef Borsig, L., Wong, R., Hynes, R. O., Varki, N. M., & Varki, A. (2002). Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proceedings of the National Academy of Sciences of the United States of America, 99(4), 2193–2198.PubMedCrossRef
47.
Zurück zum Zitat Kim, Y. J., Borsig, L., Varki, N. M., & Varki, A. (1998). P-selectin deficiency attenuates tumor growth and metastasis. Proceedings of the National Academy of Sciences of the United States of America, 95(16), 9325–9330.PubMedCrossRef Kim, Y. J., Borsig, L., Varki, N. M., & Varki, A. (1998). P-selectin deficiency attenuates tumor growth and metastasis. Proceedings of the National Academy of Sciences of the United States of America, 95(16), 9325–9330.PubMedCrossRef
48.
Zurück zum Zitat Matsuura, N., Puzon-McLaughlin, W., Irie, A., Morikawa, Y., Kakudo, K., & Takada, Y. (1996). Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. American Journal of Pathology, 148(1), 55–61.PubMed Matsuura, N., Puzon-McLaughlin, W., Irie, A., Morikawa, Y., Kakudo, K., & Takada, Y. (1996). Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. American Journal of Pathology, 148(1), 55–61.PubMed
49.
Zurück zum Zitat Langley, R. R., Carlisle, R., Ma, L., Specian, R. D., Gerritsen, M. E., & Granger, D. N. (2001). Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma. Microcirculation, 8(5), 335–345.PubMed Langley, R. R., Carlisle, R., Ma, L., Specian, R. D., Gerritsen, M. E., & Granger, D. N. (2001). Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma. Microcirculation, 8(5), 335–345.PubMed
50.
Zurück zum Zitat Ruoslahti, E., & Rajotte, D. (2000). An address system in the vasculature of normal tissues and tumors. Annual Review of Immunology, 18, 813–827.PubMedCrossRef Ruoslahti, E., & Rajotte, D. (2000). An address system in the vasculature of normal tissues and tumors. Annual Review of Immunology, 18, 813–827.PubMedCrossRef
51.
Zurück zum Zitat McMenamin, M. M., Hayle, A. J., Darling, D. L., et al. (1988). Genetic basis of metastases. Advances in Experimental Medicine and Biology, 233, 269–279.PubMed McMenamin, M. M., Hayle, A. J., Darling, D. L., et al. (1988). Genetic basis of metastases. Advances in Experimental Medicine and Biology, 233, 269–279.PubMed
52.
Zurück zum Zitat Boyer, B., Tucker, G. C., Valles, A. M., Gavrilovic, J., & Thiery, J. P. (1989). Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line. International Journal of Cancer. Supplement, 4, 69–75.CrossRef Boyer, B., Tucker, G. C., Valles, A. M., Gavrilovic, J., & Thiery, J. P. (1989). Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line. International Journal of Cancer. Supplement, 4, 69–75.CrossRef
53.
Zurück zum Zitat Zavadil, J., Haley, J., Kalluri, R., Muthuswamy, S. K., & Thompson, E. (2008). Epithelial–mesenchymal transition. Cancer Research, 68(23), 9574–9577.PubMedCrossRef Zavadil, J., Haley, J., Kalluri, R., Muthuswamy, S. K., & Thompson, E. (2008). Epithelial–mesenchymal transition. Cancer Research, 68(23), 9574–9577.PubMedCrossRef
54.
Zurück zum Zitat Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial–mesenchymal transition. The Journal of Clinical Investigation, 119(6), 1420–1428.PubMedCrossRef Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial–mesenchymal transition. The Journal of Clinical Investigation, 119(6), 1420–1428.PubMedCrossRef
55.
Zurück zum Zitat Taube, J. H., Herschkowitz, J. I., Komurov, K., et al. (2010). Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proceedings of the National Academy of Sciences of the United States of America, 107(35), 15449–15454.PubMedCrossRef Taube, J. H., Herschkowitz, J. I., Komurov, K., et al. (2010). Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proceedings of the National Academy of Sciences of the United States of America, 107(35), 15449–15454.PubMedCrossRef
56.
Zurück zum Zitat Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nature Reviews. Cancer, 9(4), 265–273.PubMedCrossRef Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nature Reviews. Cancer, 9(4), 265–273.PubMedCrossRef
57.
Zurück zum Zitat Tarin, D. (2005). The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Research, 65(14), 5996–6000.PubMedCrossRef Tarin, D. (2005). The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Research, 65(14), 5996–6000.PubMedCrossRef
58.
Zurück zum Zitat Osterreicher, C. H., Penz-Osterreicher, M., Grivennikov, S. I., et al. (2011). Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proceedings of the National Academy of Sciences of the United States of America, 108(1), 308–313.PubMedCrossRef Osterreicher, C. H., Penz-Osterreicher, M., Grivennikov, S. I., et al. (2011). Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proceedings of the National Academy of Sciences of the United States of America, 108(1), 308–313.PubMedCrossRef
59.
Zurück zum Zitat Humphreys, B. D., Lin, S. L., Kobayashi, A., et al. (2010). Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. American Journal of Pathology, 176(1), 85–97.PubMedCrossRef Humphreys, B. D., Lin, S. L., Kobayashi, A., et al. (2010). Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. American Journal of Pathology, 176(1), 85–97.PubMedCrossRef
60.
Zurück zum Zitat Spemann, H. (1938). Embryonic induction and development. New Haven, CT: Yale University Press. Spemann, H. (1938). Embryonic induction and development. New Haven, CT: Yale University Press.
61.
Zurück zum Zitat Grobstein, C. (1953). Morphogenetic interaction between embryonic mouse tissues separated by a membrane filter. Nature, 172(4384), 869–870.PubMedCrossRef Grobstein, C. (1953). Morphogenetic interaction between embryonic mouse tissues separated by a membrane filter. Nature, 172(4384), 869–870.PubMedCrossRef
62.
Zurück zum Zitat Kratochwil, K. (1972). Tissue interaction during embryonic development. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 1–47). London: Academic. Kratochwil, K. (1972). Tissue interaction during embryonic development. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 1–47). London: Academic.
63.
Zurück zum Zitat Saxén, L. (1972). Interactive mechanisms in morphogenesis. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 49–80). London: Academic. Saxén, L. (1972). Interactive mechanisms in morphogenesis. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 49–80). London: Academic.
64.
Zurück zum Zitat Tarin, D. (1972). Tissue interactions in morphogenesis, morphostasis and carcinogenesis. Journal of Theoretical Biology, 34(1), 61–72.PubMedCrossRef Tarin, D. (1972). Tissue interactions in morphogenesis, morphostasis and carcinogenesis. Journal of Theoretical Biology, 34(1), 61–72.PubMedCrossRef
65.
Zurück zum Zitat Tarin, D. (1972). Tissue interactions and the maintenance of histological structure in adults. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 81–93). London: Academic. Tarin, D. (1972). Tissue interactions and the maintenance of histological structure in adults. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 81–93). London: Academic.
66.
Zurück zum Zitat Tarin, D., Price, J. E., Kettlewell, M. G., Souter, R. G., Vass, A. C., & Crossley, B. (1984). Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Research, 44(8), 3584–3592.PubMed Tarin, D., Price, J. E., Kettlewell, M. G., Souter, R. G., Vass, A. C., & Crossley, B. (1984). Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Research, 44(8), 3584–3592.PubMed
67.
Zurück zum Zitat Tarin, D., & Price, J. E. (1981). Influence of microenvironment and vascular anatomy on “metastatic” colonization potential of mammary tumors. Cancer Research, 41(9 Pt 1), 3604–3609.PubMed Tarin, D., & Price, J. E. (1981). Influence of microenvironment and vascular anatomy on “metastatic” colonization potential of mammary tumors. Cancer Research, 41(9 Pt 1), 3604–3609.PubMed
68.
Zurück zum Zitat Tarin, D. (2006). New insights into the pathogenesis of breast cancer metastasis. Breast Disease, 26, 13–25.PubMed Tarin, D. (2006). New insights into the pathogenesis of breast cancer metastasis. Breast Disease, 26, 13–25.PubMed
69.
Zurück zum Zitat Hart, I. R., & Fidler, I. J. (1980). Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Research, 40(7), 2281–2287.PubMed Hart, I. R., & Fidler, I. J. (1980). Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Research, 40(7), 2281–2287.PubMed
70.
Zurück zum Zitat Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M., & Fidler, I. J. (1988). Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Research, 48(23), 6863–6871.PubMed Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M., & Fidler, I. J. (1988). Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Research, 48(23), 6863–6871.PubMed
71.
Zurück zum Zitat Naito, S., von Eschenbach, A. C., Giavazzi, R., & Fidler, I. J. (1986). Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Research, 46(8), 4109–4115.PubMed Naito, S., von Eschenbach, A. C., Giavazzi, R., & Fidler, I. J. (1986). Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Research, 46(8), 4109–4115.PubMed
72.
Zurück zum Zitat Lucke, B. (1938). Carcinoma in the leopard frog: Its probable causation by a virus. The Journal of Experimental Medicine, 68(4), 457–468.PubMedCrossRef Lucke, B. (1938). Carcinoma in the leopard frog: Its probable causation by a virus. The Journal of Experimental Medicine, 68(4), 457–468.PubMedCrossRef
73.
Zurück zum Zitat Lucke, B., & Schlumberger, H. (1949). Induction of metastasis of frog carcinoma by increase of environmental temperature. The Journal of Experimental Medicine, 89(3), 269–278.PubMedCrossRef Lucke, B., & Schlumberger, H. (1949). Induction of metastasis of frog carcinoma by increase of environmental temperature. The Journal of Experimental Medicine, 89(3), 269–278.PubMedCrossRef
74.
Zurück zum Zitat McKinnell, R. G., & Tarin, D. (1984). Temperature-dependent metastasis of the Lucke renal carcinoma and its significance for studies on mechanisms of metastasis. Cancer and Metastasis Reviews, 3(4), 373–386.PubMedCrossRef McKinnell, R. G., & Tarin, D. (1984). Temperature-dependent metastasis of the Lucke renal carcinoma and its significance for studies on mechanisms of metastasis. Cancer and Metastasis Reviews, 3(4), 373–386.PubMedCrossRef
75.
Zurück zum Zitat Sugino, T., Gorham, H., Yoshida, K., et al. (1996). Progressive loss of CD44 gene expression in invasive bladder cancer. American Journal of Pathology, 149(3), 873–882.PubMed Sugino, T., Gorham, H., Yoshida, K., et al. (1996). Progressive loss of CD44 gene expression in invasive bladder cancer. American Journal of Pathology, 149(3), 873–882.PubMed
76.
Zurück zum Zitat Sugino, T., Yoshida, K., Zhao, S., Goodison, S., & Tarin, D. (1998). Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions. The Journal of Pathology, 186(1), 17–23.PubMedCrossRef Sugino, T., Yoshida, K., Zhao, S., Goodison, S., & Tarin, D. (1998). Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions. The Journal of Pathology, 186(1), 17–23.PubMedCrossRef
77.
Zurück zum Zitat Tarin, D. (2011). Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance. Seminars in Cancer Biology, 21, 72–82.PubMedCrossRef Tarin, D. (2011). Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance. Seminars in Cancer Biology, 21, 72–82.PubMedCrossRef
78.
Zurück zum Zitat Macaulay, V. M., & Smith, J. E. (1996). Paraneoplastic syndromes. In M. Peckham, H. M. Pinedo, & U. Veronesi (Eds.), Oxford textbook of oncology (pp. 2228–2253). Oxford: Oxford University Press. Macaulay, V. M., & Smith, J. E. (1996). Paraneoplastic syndromes. In M. Peckham, H. M. Pinedo, & U. Veronesi (Eds.), Oxford textbook of oncology (pp. 2228–2253). Oxford: Oxford University Press.
79.
Zurück zum Zitat Lucke, B., & Berwick, M. (1954). Catalase activity of liver and kidney in frogs with spontaneous renal carcinoma. The Journal of Experimental Medicine, 100(2), 125–133.PubMedCrossRef Lucke, B., & Berwick, M. (1954). Catalase activity of liver and kidney in frogs with spontaneous renal carcinoma. The Journal of Experimental Medicine, 100(2), 125–133.PubMedCrossRef
80.
Zurück zum Zitat Feng, W., McCabe, N. P., Mahabeleshwar, G. H., Somanath, P. R., Phillips, D. R., & Byzova, T. V. (2008). The angiogenic response is dictated by beta3 integrin on bone marrow-derived cells. The Journal of Cell Biology, 183(6), 1145–1157.PubMedCrossRef Feng, W., McCabe, N. P., Mahabeleshwar, G. H., Somanath, P. R., Phillips, D. R., & Byzova, T. V. (2008). The angiogenic response is dictated by beta3 integrin on bone marrow-derived cells. The Journal of Cell Biology, 183(6), 1145–1157.PubMedCrossRef
81.
Zurück zum Zitat Carotta, S., Holmes, M. L., Pridans, C., & Nutt, S. L. (2006). Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation. Cell Cycle, 5(21), 2452–2456.PubMedCrossRef Carotta, S., Holmes, M. L., Pridans, C., & Nutt, S. L. (2006). Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation. Cell Cycle, 5(21), 2452–2456.PubMedCrossRef
82.
Zurück zum Zitat Miyamoto, T., & Akashi, K. (2005). Lineage promiscuous expression of transcription factors in normal hematopoiesis. International Journal of Hematology, 81(5), 361–367.PubMedCrossRef Miyamoto, T., & Akashi, K. (2005). Lineage promiscuous expression of transcription factors in normal hematopoiesis. International Journal of Hematology, 81(5), 361–367.PubMedCrossRef
83.
Zurück zum Zitat Caretti, G., Di Padova, M., Micales, B., Lyons, G. E., & Sartorelli, V. (2004). The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes & Development, 18(21), 2627–2638.CrossRef Caretti, G., Di Padova, M., Micales, B., Lyons, G. E., & Sartorelli, V. (2004). The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes & Development, 18(21), 2627–2638.CrossRef
84.
Zurück zum Zitat Mayer, R., Raventos, D., & Chua, N. H. (1996). det1, cop1, and cop9 mutations cause inappropriate expression of several gene sets. The Plant Cell, 8(11), 1951–1959.PubMedCrossRef Mayer, R., Raventos, D., & Chua, N. H. (1996). det1, cop1, and cop9 mutations cause inappropriate expression of several gene sets. The Plant Cell, 8(11), 1951–1959.PubMedCrossRef
85.
Zurück zum Zitat Lamprecht, B., Walter, K., Kreher, S., et al. (2010). Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nature Medicine, 16(5), 571–579.PubMedCrossRef Lamprecht, B., Walter, K., Kreher, S., et al. (2010). Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nature Medicine, 16(5), 571–579.PubMedCrossRef
86.
Zurück zum Zitat Engel, M. E., & Hiebert, S. W. (2010). The enemy within: Dormant retroviruses awaken. Nature Medicine, 16(5), 517–518.PubMedCrossRef Engel, M. E., & Hiebert, S. W. (2010). The enemy within: Dormant retroviruses awaken. Nature Medicine, 16(5), 517–518.PubMedCrossRef
87.
Zurück zum Zitat Mueller, J., Gazzoli, I., Bandipalliam, P., Garber, J. E., Syngal, S., & Kolodner, R. D. (2009). Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Research, 69(17), 7053–7061.PubMedCrossRef Mueller, J., Gazzoli, I., Bandipalliam, P., Garber, J. E., Syngal, S., & Kolodner, R. D. (2009). Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Research, 69(17), 7053–7061.PubMedCrossRef
88.
Zurück zum Zitat Moura Lima, E., Ferreira Leal, M., Cardoso Smith Mde, A., et al. (2008). DNA mismatch repair gene methylation in gastric cancer in individuals from northern Brazil. Biocell, 32(3), 237–243.PubMed Moura Lima, E., Ferreira Leal, M., Cardoso Smith Mde, A., et al. (2008). DNA mismatch repair gene methylation in gastric cancer in individuals from northern Brazil. Biocell, 32(3), 237–243.PubMed
89.
Zurück zum Zitat Thon, N., Eigenbrod, S., Grasbon-Frodl, E. M., et al. (2011). Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide. Journal of Neurology, Neurosurgery, and Psychiatry, 82, 441–446.PubMedCrossRef Thon, N., Eigenbrod, S., Grasbon-Frodl, E. M., et al. (2011). Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide. Journal of Neurology, Neurosurgery, and Psychiatry, 82, 441–446.PubMedCrossRef
90.
Zurück zum Zitat Lahtz, C., & Pfeifer, G. P. (2011). Epigenetic changes of DNA repair genes in cancer. Journal of Molecular Cell Biology, 3(1), 51–58.PubMedCrossRef Lahtz, C., & Pfeifer, G. P. (2011). Epigenetic changes of DNA repair genes in cancer. Journal of Molecular Cell Biology, 3(1), 51–58.PubMedCrossRef
91.
Zurück zum Zitat Villarreal, L. P., & Witzany, G. (2010). Viruses are essential agents within the roots and stem of the tree of life. Journal of Theoretical Biology, 262(4), 698–710.PubMedCrossRef Villarreal, L. P., & Witzany, G. (2010). Viruses are essential agents within the roots and stem of the tree of life. Journal of Theoretical Biology, 262(4), 698–710.PubMedCrossRef
92.
Zurück zum Zitat Kennedy, J. F. (1962). Speech to Rice University on the launching of the moon landing program, 9th December 1962. Kennedy, J. F. (1962). Speech to Rice University on the launching of the moon landing program, 9th December 1962.
Metadaten
Titel
Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance
verfasst von
David Tarin
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Cancer and Metastasis Reviews / Ausgabe 1-2/2012
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-011-9326-8

Weitere Artikel der Ausgabe 1-2/2012

Cancer and Metastasis Reviews 1-2/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.